Clinical Trial of Safety and Efficacy of IHN-A21 for the Prevention of Nosocomial Staphylococcal Bloodstream Infection in Premature Infants
- 1 September 2007
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 151 (3) , 260-265.e1
- https://doi.org/10.1016/j.jpeds.2007.04.060
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Neurodevelopmental and Growth Impairment Among Extremely Low-Birth-Weight Infants With Neonatal InfectionJAMA, 2004
- Features of Invasive Staphylococcal Disease in NeonatesPediatrics, 2004
- Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infantsPublished by Wiley ,2004
- The NICHD neonatal research network: changes in practice and outcomes during the first 15 yearsSeminars in Perinatology, 2003
- Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research NetworkPediatrics, 2002
- Additional confirmation of the lack of effect of intravenous immunoglobulin in the prevention of neonatal infectionThe Journal of Pediatrics, 2000
- Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infantsThe Pediatric Infectious Disease Journal, 1998
- Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research NetworkThe Journal of Pediatrics, 1996
- A Controlled Trial of Intravenous Immune Globulin to Reduce Nosocomial Infections in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1994
- Intravenous Immune Globulin for the Prevention of Nosocomial Infection in Low-Birth-Weight NeonatesNew England Journal of Medicine, 1992